sintilimab,anlotinib
eli lilly,Innovent Biologics,advenchen,sino biopharmaceuticals
['sintilimab', 'anlotinib']
very encouraging results of sintilimab (antipd1) + anlotinib (antiagiogenic).
safety profile interesting. goes in phase 3 globally?
#esmo2022 
Head of pulmonology unit @pneumo_LS @CHUdeLyon
Professor of Pulmonology @UnivLyon1
Scientific head @URCOT_lyon & @IFCTlung
#liquidbiopsy~#screening~????